{"id":"https://openalex.org/W4283381089","doi":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","title":"P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2","display_name":"P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283381089","doi":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000847336.10486.b2","doi":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086537029","display_name":"M. L. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. L. Wang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Munoz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154023","display_name":"Banner MD Anderson Cancer Center","ror":"https://ror.org/049c9q337","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802412784","https://openalex.org/I4387154023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Munoz","raw_affiliation_strings":["Banner MD Anderson Cancer Center, Gilbert, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Banner MD Anderson Cancer Center, Gilbert, AZ","institution_ids":["https://openalex.org/I4387154023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089882481","display_name":"Andre Henri Goy","orcid":"https://orcid.org/0000-0001-5125-6522","observed_orcids":["https://orcid.org/0000-0001-5125-6522"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Goy","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack University, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack University, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072119147","display_name":"Frederick L. Locke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. L. Locke","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037526878","display_name":"Caron Alyce Jacobson","orcid":"https://orcid.org/0000-0002-0180-0654","observed_orcids":["https://orcid.org/0000-0002-0180-0654"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. A. Jacobson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061999823","display_name":"B. T. Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. T. Hill","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. M. Timmerman","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028522864","display_name":"Holli M. Holmes","orcid":"https://orcid.org/0009-0006-5224-0729","observed_orcids":["https://orcid.org/0009-0006-5224-0729"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Holmes","raw_affiliation_strings":["Texas Oncology, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology, Dallas, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000959540","display_name":"Ian W. Flinn","orcid":"https://orcid.org/0000-0001-6724-290X","observed_orcids":["https://orcid.org/0000-0001-6724-290X"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. W. Flinn","raw_affiliation_strings":["Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081926380","display_name":"David Bernard Miklos","orcid":"https://orcid.org/0000-0003-0717-4305","observed_orcids":["https://orcid.org/0000-0003-0717-4305"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. B. Miklos","raw_affiliation_strings":["Stanford University School of Medicine, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040412322","display_name":"John M. Pagel","orcid":"https://orcid.org/0000-0001-5745-8125","observed_orcids":["https://orcid.org/0000-0001-5745-8125","https://orcid.org/0000-0003-2875-4878"]},"institutions":[{"id":"https://openalex.org/I4210093417","display_name":"Swedish Medical Center","ror":"https://ror.org/004jktf35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093417","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. M. Pagel","raw_affiliation_strings":["Swedish Cancer Institute, Seattle, WA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Cancer Institute, Seattle, WA, United States of America","institution_ids":["https://openalex.org/I4210093417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036293139","display_name":"Marie Jos\u00e9 Kersten","orcid":"https://orcid.org/0000-0002-8904-3802","observed_orcids":["https://orcid.org/0000-0002-8904-3802"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. J. Kersten","raw_affiliation_strings":["Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam, The Netherlands, on behalf of HOVON/LLPC, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam, The Netherlands, on behalf of HOVON/LLPC, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031216970","display_name":"Roch Houot","orcid":"https://orcid.org/0000-0003-1729-8213","observed_orcids":["https://orcid.org/0000-0003-1729-8213"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210155724","display_name":"Centre Hospitalier Universitaire de Rennes","ror":"https://ror.org/05qec5a53","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210155724"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"R. Houot","raw_affiliation_strings":["CHU Rennes, Universit\u00e9 Rennes, INSERM & EFS, Renne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Rennes, Universit\u00e9 Rennes, INSERM & EFS, Renne, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210155724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038261300","display_name":"Amer Beitinjaneh","orcid":"https://orcid.org/0000-0002-1661-5865","observed_orcids":["https://orcid.org/0000-0002-1661-5865"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Beitinjaneh","raw_affiliation_strings":["University of Miami, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W. Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142892","display_name":"Kite (United States)","ror":"https://ror.org/04tnhnq23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Peng","raw_affiliation_strings":["Kite, a Gilead Company, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead Company, Santa Monica, CA","institution_ids":["https://openalex.org/I4210142892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030853715","display_name":"X. Fang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142892","display_name":"Kite (United States)","ror":"https://ror.org/04tnhnq23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Fang","raw_affiliation_strings":["Kite, a Gilead Company, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead Company, Santa Monica, CA","institution_ids":["https://openalex.org/I4210142892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033867275","display_name":"R. R. Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142892","display_name":"Kite (United States)","ror":"https://ror.org/04tnhnq23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. R. Shen","raw_affiliation_strings":["Kite, a Gilead Company, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead Company, Santa Monica, CA","institution_ids":["https://openalex.org/I4210142892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053397348","display_name":"R. Siddiqi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142892","display_name":"Kite (United States)","ror":"https://ror.org/04tnhnq23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Siddiqi","raw_affiliation_strings":["Kite, a Gilead Company, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead Company, Santa Monica, CA","institution_ids":["https://openalex.org/I4210142892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023792802","display_name":"Ioana Kloos","orcid":"https://orcid.org/0009-0004-3243-8450","observed_orcids":["https://orcid.org/0009-0004-3243-8450"]},"institutions":[{"id":"https://openalex.org/I4210142892","display_name":"Kite (United States)","ror":"https://ror.org/04tnhnq23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. Kloos","raw_affiliation_strings":["Kite, a Gilead Company, Santa Monica, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite, a Gilead Company, Santa Monica, CA","institution_ids":["https://openalex.org/I4210142892"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065181560","display_name":"Patrick M. Reagan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. M. Reagan","raw_affiliation_strings":["University of Rochester Medical Center, Rochester, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Rochester Medical Center, Rochester, NY, United States of America","institution_ids":["https://openalex.org/I28792581"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":21,"corresponding_author_ids":["https://openalex.org/A5086537029"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.1045,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.38985113,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"6","issue":null,"first_page":"1007","last_page":"1008"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexucabtagene-autoleucel","display_name":"brexucabtagene autoleucel","score":0.9589999914169312},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.8299999833106995},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9459999799728394},{"id":"https://openalex.org/keywords/anti-cd19-antibody","display_name":"anti-CD19","score":0.8939999938011169},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8190000057220459},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8230000138282776},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.984000027179718},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.7480000257492065},{"id":"https://openalex.org/keywords/late-recurrence","display_name":"late recurrence","score":0.718999981880188},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6800000071525574},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.4099999964237213},{"id":"https://openalex.org/keywords/conditioning-chemotherapy","display_name":"conditioning chemotherapy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/leukapheresis","display_name":"leukapheresis","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7465885281562805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6701844930648804},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6353780031204224},{"id":"https://openalex.org/C2777371436","wikidata":"https://www.wikidata.org/wiki/Q3237071","display_name":"Leukapheresis","level":4,"score":0.6250613331794739},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5945698618888855},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5440731048583984},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4203033149242401},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34503477811813354},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.11466580629348755},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.08647134900093079},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000847336.10486.b2","doi":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9430665","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9430665","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:62da40ad0f8549bbab61e5c0e22baee6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/62da40ad0f8549bbab61e5c0e22baee6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 1007-1008 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000847336.10486.b2","doi":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847336.10486.b2","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281719458","https://openalex.org/W3097804717","https://openalex.org/W4310120218","https://openalex.org/W4281901970","https://openalex.org/W3172497218","https://openalex.org/W2982836758","https://openalex.org/W3000783913","https://openalex.org/W4388673575","https://openalex.org/W4389234290","https://openalex.org/W7155684078"],"abstract_inverted_index":{"Background:":[0],"Brexucabtagene":[1],"autoleucel":[2],"(KTE-X19)":[3],"is":[4],"an":[5,103],"autologous":[6],"anti-CD19":[7],"chimeric":[8],"antigen":[9],"receptor":[10],"(CAR)":[11],"T-cell":[12,441],"therapy":[13,442],"approved":[14],"for":[15,119,187,241],"the":[16,130,239,247,262,335,436],"treatment":[17],"of":[18,75,96,152,163,217,226,285,302,311,326,331,385,407,439],"patients":[19],"(pts)":[20],"with":[21,43,47,72,83,141,161,228,277,280,445,457],"relapsed/refractory":[22],"(R/R)":[23],"mantle":[24],"cell":[25],"lymphoma":[26],"(MCL).":[27],"In":[28],"ZUMA-2,":[29],"a":[30,93,142],"93%":[31],"objective":[32],"response":[33,38,153,171],"rate":[34,145],"(ORR;":[35],"67%":[36],"complete":[37],"[CR]":[39],"rate)":[40],"was":[41,102,136,155,182,210,275,309,344,393],"reported":[42,118],"KTE-X19":[44,452],"in":[45,109,169,212,246,261,292,443,465],"pts":[46,80,166,214,250,287,355,444],"R/R":[48,84,466],"MCL":[49,85,446],"(median":[50],"follow-up:":[51],"12.3":[52],"mo;":[53],"60":[54],"efficacy-evaluable":[55],"pts;":[56],"Wang":[57],"et":[58],"al.":[59],"N":[60],"Engl":[61],"J":[62],"Med.":[63],"2020).":[64],"Aims:":[65],"To":[66],"present":[67],"updated":[68],"outcomes":[69],"from":[70],"ZUMA-2":[71],"2":[73],"years":[74],"additional":[76],"follow-up.":[77],"Methods:":[78],"Adult":[79],"(\u226518":[81],"years)":[82],"underwent":[86],"leukapheresis":[87],"and":[88,191,201,224,244,258,273,283,307,315,363,379,425,449,460],"conditioning":[89],"chemotherapy":[90],"followed":[91],"by":[92],"single":[94],"infusion":[95],"KTE-X19.":[97],"Minimal":[98],"residual":[99],"disease":[100],"(MRD)":[101],"exploratory":[104],"endpoint":[105],"(sensitivity":[106],"10-5)":[107],"evaluated":[108],"peripheral":[110],"blood":[111],"using":[112],"next-generation":[113],"sequencing.":[114],"Updated":[115],"results":[116],"are":[117],"all":[120,252],"68":[121,164],"treated":[122,165],"pts.":[123],"Results:":[124],"After":[125],"35.6":[126],"mo":[127,157,180,197,203,222,234,270,305,390,418,423,430],"median":[128,150],"follow-up,":[129],"ORR":[131],"(CR":[132],"+":[133],"partial":[134],"response)":[135],"91%":[137],"(95%":[138,146,158,198,204],"CI,":[139,147,159,199,205],"81.8-96.7),":[140],"68%":[143],"CR":[144,294],"55.2-78.5).":[148],"The":[149,185,338],"duration":[151],"(DOR)":[154],"28.2":[156],"13.5-47.1),":[160],"25":[162],"(37%)":[167],"still":[168],"ongoing":[170,293],"(all":[172],"CR)":[173],"at":[174,221,233,269,288,295,304],"data":[175,230,237,296,434],"cutoff.":[176,297],"Late":[177],"relapse":[178,312,463],">24":[179],"post-infusion":[181],"infrequent":[183],"(n=3).":[184],"medians":[186,240],"progression-free":[188],"survival":[189,193],"(PFS)":[190],"overall":[192],"(OS)":[194],"were":[195,219,231,251,322,372,409],"25.8":[196],"9.6-47.6)":[200],"46.6":[202],"24.9-not":[206],"estimable),":[207],"respectively.":[208,266],"MRD":[209,303],"analyzed":[211],"29":[213,218],"total;":[215],"24":[216],"MRD-negative":[220,232,249,267,286],"1,":[223,271],"15":[225,248],"19":[227],"available":[229],"6.":[235],"At":[236],"cutoff,":[238],"DOR,":[242],"PFS,":[243],"OS":[245],"not":[253,395],"reached,":[254],"vs":[255],"6.1,":[256],"7.1,":[257],"27.0":[259],"mo,":[260],"4":[263],"MRD-positive":[264],"pts,":[265],"status":[268],"3,":[272],"6":[274,308],"associated":[276],"durable":[278,454],"response,":[279],"55%,":[281],"71%,":[282],"69%":[284],"those":[289],"timepoints":[290],"remaining":[291],"Circulating":[298],"tumor":[299],"DNA":[300],"analysis":[301],"3":[306,359,387],"predictive":[310],"(AUC":[313],"0.80":[314],"0.75,":[316],"respectively).":[317],"No":[318],"new":[319,374,381,401],"safety":[320,459],"signals":[321],"observed.":[323],"Only":[324],"3%":[325],"treatment-emergent":[327],"adverse":[328],"events":[329],"(AEs)":[330],"interest":[332],"occurred":[333],"since":[334],"primary":[336],"report.":[337],"most":[339],"frequent":[340],"Grade":[341,348,352,358,386,402],"\u22653":[342],"AE":[343,384],"neutropenia":[345],"(1":[346],"[1%]":[347],"3;":[349],"7":[350],"[10%]":[351],"4).":[353],"Two":[354],"had":[356],"KTE-X19-related":[357],"serious":[360,382],"infections:":[361],"pneumonia":[362],"upper":[364],"respiratory":[365],"tract":[366],"infection":[367],"(n=1);":[368],"influenza":[369],"(n=1).":[370],"There":[371],"no":[373],"cytokine":[375],"release":[376],"syndrome":[377,421],"AEs":[378,404],"1":[380],"neurologic":[383],"encephalopathy":[388],"(13.0":[389],"post-infusion)":[391],"that":[392,451],"considered":[394,410],"related":[396,411],"to":[397,412,447],"study":[398,413],"treatment.":[399],"Three":[400],"5":[403],"occurred,":[405],"none":[406],"which":[408],"treatment:":[414],"Salmonella":[415],"bacteremia":[416],"(24.9":[417],"post-infusion),":[419,424],"myelodysplastic":[420],"(25.2":[422],"acute":[426],"myeloid":[427],"leukemia":[428],"(37.5":[429],"post-infusion).":[431],"Summary/Conclusion:":[432],"These":[433],"represent":[435],"longest":[437],"follow-up":[438],"CAR":[440],"date":[448],"suggest":[450],"induces":[453],"long-term":[455],"responses":[456],"manageable":[458],"low":[461],"late":[462],"potential":[464],"MCL.":[467]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-06-25T00:00:00"}